Health Economic Assessment of Nirsevimab for Re...

By Charmi Patel

July 23, 2024

Introduction
Game-Changer in Atopic Dermatitis Care: Abrocitinib’s Cost-Effectivenes...
The Role of Real-World Evidence in CMS Price Negotiations
The Role of Pull Incentives in Addressing Antimicrobial Resistance
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Strategies for Fair Drug Pricing: Balancing Pharmacy Viability and Cost Conta...
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Biosimilar Competition and Patient Out-of-Pocket Costs
Insights into Austria’s Pricing and Pharmaceutical Policy
COPD Management: Evidence Report on Ensifentrine